Brought to you by 
Viamet files for IPO; withdrawn; later revived; postpones once again
20 Jul 2022
Executive Summary
After initially filing for its IPO in June 2014 and then withdrawing the offering four months later, antifungals developer Viamet Pharmaceuticals Corp. (formerly Viamet Pharmaceuticals Holdings LLC) is attempting to go public again.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Viamet files for IPO; withdrawn; later revived; postpones once again
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice